Smart pill could spot hidden danger in your belly
NCT ID NCT06709924
First seen Jan 11, 2026 · Last updated Jun 21, 2026 · Updated 20 times
Summary
This completed trial tested a swallowable smart capsule called PressureDOT that measures pressure inside the abdomen. Twenty healthy people swallowed the capsule and did exercise while the device sent pressure data wirelessly. The goal was to see if the capsule can safely and accurately detect elevated intra-abdominal pressure, a condition that can signal serious health problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRAABDOMINAL PRESSURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
China Medical University &Hospital
Taichung, 40454, Taiwan
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
PressureDOT smart capsule (pressure-sensing ingestible device)
What this could lead to
If successful, this could provide a safer, wireless way to detect dangerous internal pressure early, reducing infections from current methods.
What could go wrong
This is a very small, early-phase trial with only 20 healthy people. The capsule may not work reliably in real patients, and there is a small risk of it getting stuck.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.